Literature DB >> 18834318

International outbreak of severe botulism with prolonged toxemia caused by commercial carrot juice.

Anandi N Sheth1, Petra Wiersma, David Atrubin, Vinita Dubey, Donald Zink, Guy Skinner, Fran Doerr, Patricia Juliao, German Gonzalez, Cindy Burnett, Cherie Drenzek, Carrie Shuler, John Austin, Andrea Ellis, Susan Maslanka, Jeremy Sobel.   

Abstract

BACKGROUND: On 8 September 2006, 3 Georgia residents presented with symptoms of food-borne botulism, a potentially fatal illness caused by Clostridium botulinum neurotoxins.
METHODS: Investigators reviewed medical records and interviewed patients and family members. Foods from patients' homes and samples of the implicated commercial beverage were tested for botulinum toxin and C. botulinum by standard methods.
RESULTS: The patients presented with cranial neuropathies and flaccid paralysis; all patients required mechanical ventilation. The 3 Georgia patients had consumed carrot juice from the same bottle before illness onset. An additional case in Florida and 2 in Ontario, Canada, were subsequently identified in patients who had consumed carrot juice. Serum samples obtained from 5 patients tested positive for botulinum toxin type A-in one patient, 12 days after illness onset, and in another patient, 25 days after illness onset. Carrot juice produced by 1 manufacturer, recovered from patients' homes in Georgia, Florida, and Ontario, yielded type A toxin. The juice contained no added sugar, salt, or preservative; inappropriate refrigeration likely resulted in botulinum toxin production.
CONCLUSION: This outbreak was caused by commercially produced, internationally distributed carrot juice that was contaminated with botulinum toxin. When toxemia persists, treatment for botulism should be considered even if diagnosed weeks after illness onset. The implicated pasteurized carrot juice had no barriers to growth of C. botulinum other than refrigeration; additional protective measures for carrot juice are needed to prevent future outbreaks. The US Food and Drug Administration has since issued industry guidance to reduce the risk of C. botulinum intoxication from low-acid refrigerated juices.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18834318     DOI: 10.1086/592574

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

1.  Subtyping botulinum neurotoxins by sequential multiple endoproteases in-gel digestion coupled with mass spectrometry.

Authors:  Dongxia Wang; Jakub Baudys; Jon Rees; Kristin M Marshall; Suzanne R Kalb; Bryan A Parks; Louis Nowaczyk; James L Pirkle; John R Barr
Journal:  Anal Chem       Date:  2012-05-21       Impact factor: 6.986

2.  Clinically and electrophysiologically diagnosed botulinum intoxication.

Authors:  Dilcan Kotan; Recep Aygul; Mustafa Ceylan; Yalcin Yilikoglu
Journal:  BMJ Case Rep       Date:  2013-01-03

Review 3.  Botulinum neurotoxins: genetic, structural and mechanistic insights.

Authors:  Ornella Rossetto; Marco Pirazzini; Cesare Montecucco
Journal:  Nat Rev Microbiol       Date:  2014-06-30       Impact factor: 60.633

4.  Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin.

Authors:  Patricia A Yu; Neal H Lin; Barbara E Mahon; Jeremy Sobel; Yon Yu; Rajal K Mody; Weidong Gu; Jennifer Clements; Hye-Joo Kim; Agam K Rao
Journal:  Clin Infect Dis       Date:  2017-12-27       Impact factor: 9.079

5.  Efficacy of Antitoxin Therapy in Treating Patients With Foodborne Botulism: A Systematic Review and Meta-analysis of Cases, 1923-2016.

Authors:  John C O'Horo; Eugene P Harper; Abdelghani El Rafei; Rashid Ali; Daniel C DeSimone; Amra Sakusic; Omar M Abu Saleh; Jasmine R Marcelin; Eugene M Tan; Agam K Rao; Jeremy Sobel; Pritish K Tosh
Journal:  Clin Infect Dis       Date:  2017-12-27       Impact factor: 9.079

6.  Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021.

Authors:  Agam K Rao; Jeremy Sobel; Kevin Chatham-Stephens; Carolina Luquez
Journal:  MMWR Recomm Rep       Date:  2021-05-07

7.  Botulinum and Tetanus Neurotoxin-Induced Blockade of Synaptic Transmission in Networked Cultures of Human and Rodent Neurons.

Authors:  Phillip H Beske; Aaron B Bradford; Justin O Grynovicki; Elliot J Glotfelty; Katie M Hoffman; Kyle S Hubbard; Kaylie M Tuznik; Patrick M McNutt
Journal:  Toxicol Sci       Date:  2015-11-28       Impact factor: 4.849

Review 8.  Botulinum toxin: bioweapon & magic drug.

Authors:  Ram Kumar Dhaked; Manglesh Kumar Singh; Padma Singh; Pallavi Gupta
Journal:  Indian J Med Res       Date:  2010-11       Impact factor: 2.375

9.  Intestinal toxemia botulism in 3 adults, Ontario, Canada, 2006-2008.

Authors:  Yolanda D Sheppard; Dean Middleton; Yvonne Whitfield; Felix Tyndel; Shariq Haider; Jamie Spiegelman; Richard H Swartz; Mark P Nelder; Stacey L Baker; Lisa Landry; Ross Maceachern; Sherri Deamond; Lorrie Ross; Garth Peters; Michelle Baird; David Rose; Greg Sanders; John W Austin
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

10.  Rapid detection and quantitation of dipicolinic acid from Clostridium botulinum spores using mixed-mode liquid chromatography-tandem mass spectrometry.

Authors:  Benjamin W Redan; Travis R Morrissey; Catherine A Rolfe; Viviana L Aguilar; Guy E Skinner; N Rukma Reddy
Journal:  Anal Bioanal Chem       Date:  2022-02-02       Impact factor: 4.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.